Temporal Risk of Nonfatal Cardiovascular Events After Chronic Obstructive Pulmonary Disease Exacerbation: A Population-based StudyEmily L. Graul, Jennifer K Quint, Clémentine Nordon et al.|American Journal of Respiratory and Critical Care Medicine|2023Cited by 79
FET fusion oncoproteins disrupt physiologic DNA repair and create a targetable opportunity for ATR inhibitor therapyShruti Menon, Asmin Tulpule|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 5
Factors associated with non-fatal heart failure and atrial fibrillation or flutter within the first 30 days post COPD exacerbation: a nested case-control studyEmily L. Graul, Jennifer K Quint, Kirsty Rhodes et al.|BMC Pulmonary Medicine|2024Cited by 3
S86 Factors associated with non-fatal atrial fibrillation or flutter within the first 30 days post-exacerbation of COPD: a nested case-control studyEmily L. Graul, Jennifer K Quint, Clémentine Nordon et al.|Unknown|2023Cited by 0
Factors associated with non-fatal heart failure and atrial fibrillation or flutter within the first 30 days post COPD exacerbation: a nested case-control studyEmily L. Graul, Jennifer K Quint, Clémentine Nordon et al.|Research Square|2024Cited by 0